$ZIMV
ZimVie Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023017217 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $224.9M $225.4M
YoY Change -4.12% -4.32%
Cost Of Revenue $74.50M $71.05M
YoY Change -8.11% -17.2%
Gross Profit $150.4M $154.4M
YoY Change -2.02% 3.06%
Gross Profit Margin 66.87% 68.48%
Selling, General & Admin $128.5M $128.0M
YoY Change 1.93% -4.58%
% of Gross Profit 85.43% 82.89%
Research & Development $13.23M $15.37M
YoY Change -13.42% -12.92%
% of Gross Profit 8.8% 9.96%
Depreciation & Amortization $31.96M $32.63M
YoY Change 7.55% 0.24%
% of Gross Profit 21.25% 21.14%
Operating Expenses $246.7M $241.6M
YoY Change -3.66% -9.94%
Operating Profit -$21.82M -$16.13M
YoY Change 1.31% -50.57%
Interest Expense $9.005M $8.966M
YoY Change 84.0% 1161.04%
% of Operating Profit
Other Income/Expense, Net $598.0K -$906.0K
YoY Change 458.88% -455.29%
Pretax Income -$30.23M -$26.00M
YoY Change 14.83% -21.41%
Income Tax -$6.853M $3.970M
% Of Pretax Income
Net Earnings -$23.37M -$29.97M
YoY Change 168.29% 16.81%
Net Earnings / Revenue -10.39% -13.29%
Basic Earnings Per Share -$0.89 -$1.14
Diluted Earnings Per Share -$0.89 -$1.14
COMMON SHARES
Basic Shares Outstanding 26.38M 26.24M
Diluted Shares Outstanding 26.33M 26.26K

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.21M $66.41M
YoY Change -49.09% -36.3%
Cash & Equivalents $66.21M $66.41M
Short-Term Investments
Other Short-Term Assets $45.51M $31.69M
YoY Change -10.1% -35.88%
Inventory $227.5M $231.1M
Prepaid Expenses
Receivables $168.1M $175.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $507.4M $504.2M
YoY Change -11.59% -8.18%
LONG-TERM ASSETS
Property, Plant & Equipment $129.7M $139.3M
YoY Change -20.4% -18.32%
Goodwill $261.2M $261.1M
YoY Change 1.01% -0.71%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $37.66M $39.43M
YoY Change -26.38% -29.08%
Total Long-Term Assets $1.053B $1.084B
YoY Change -9.11% -11.53%
TOTAL ASSETS
Total Short-Term Assets $507.4M $504.2M
Total Long-Term Assets $1.053B $1.084B
Total Assets $1.561B $1.588B
YoY Change -9.93% -10.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.42M $52.59M
YoY Change 38.11% 34.47%
Accrued Expenses $64.69M $61.79M
YoY Change 13.89% 10.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $189.7M $196.5M
YoY Change -23.12% -10.49%
LONG-TERM LIABILITIES
Long-Term Debt $522.3M $522.0M
YoY Change -3.05% -3.67%
Other Long-Term Liabilities $10.33M $9.515M
YoY Change -32.32% -18.97%
Total Long-Term Liabilities $532.6M $531.5M
YoY Change -3.85% -4.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $189.7M $196.5M
Total Long-Term Liabilities $532.6M $531.5M
Total Liabilities $832.7M $844.5M
YoY Change -13.98% -12.2%
SHAREHOLDERS EQUITY
Retained Earnings -$100.9M -$77.50M
YoY Change 459.81% 732.71%
Common Stock $265.0K $264.0K
YoY Change 1.53% 1.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $727.8M $743.6M
YoY Change
Total Liabilities & Shareholders Equity $1.561B $1.588B
YoY Change -9.93% -10.49%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$23.37M -$29.97M
YoY Change 168.29% 16.81%
Depreciation, Depletion And Amortization $31.96M $32.63M
YoY Change 7.55% 0.24%
Cash From Operating Activities $256.0K -$7.196M
YoY Change -99.37% -27.31%
INVESTING ACTIVITIES
Capital Expenditures $1.267M $3.838M
YoY Change -120.54% -163.05%
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.994M
YoY Change -100.0% -0.3%
Cash From Investing Activities -$1.267M -$5.832M
YoY Change -79.28% -27.88%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.165M -10.94M
YoY Change -134.03% -149.37%
NET CHANGE
Cash From Operating Activities 256.0K -7.196M
Cash From Investing Activities -1.267M -5.832M
Cash From Financing Activities 1.165M -10.94M
Net Change In Cash 154.0K -23.19M
YoY Change -99.5% -700.7%
FREE CASH FLOW
Cash From Operating Activities $256.0K -$7.196M
Capital Expenditures $1.267M $3.838M
Free Cash Flow -$1.011M -$11.03M
YoY Change -102.16% 189.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2023Q1 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AssetsCurrent
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AssetsCurrent
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001876588
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Derivative Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1588059000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1642056000
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41242
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ZIMVIE INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2007795
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10225 Westmoor Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Westminster
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80021
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
443-7500
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
ZIMV
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26380737
CY2023Q1 us-gaap Revenues
Revenues
225427000
CY2022Q1 us-gaap Revenues
Revenues
235601000
CY2023Q1 zimv Cost Of Products Sold Excluding Intangible Asset Amortization
CostOfProductsSoldExcludingIntangibleAssetAmortization
70717000
CY2022Q1 zimv Cost Of Products Sold Excluding Intangible Asset Amortization
CostOfProductsSoldExcludingIntangibleAssetAmortization
85010000
CY2023Q1 zimv Related Party Cost Of Products Sold Excluding Intangible Asset Amortization
RelatedPartyCostOfProductsSoldExcludingIntangibleAssetAmortization
328000
CY2022Q1 zimv Related Party Cost Of Products Sold Excluding Intangible Asset Amortization
RelatedPartyCostOfProductsSoldExcludingIntangibleAssetAmortization
797000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20509000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20905000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15373000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17653000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
127968000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134112000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4975000
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
742000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1683000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9005000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
241553000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
268224000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16126000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-32623000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-906000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
255000
CY2023Q1 us-gaap Interest Expense
InterestExpense
8966000
CY2022Q1 us-gaap Interest Expense
InterestExpense
711000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25998000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33079000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3970000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7423000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-29968000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-25656000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-29968000
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-25656000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10517000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14666000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10517000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14666000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19451000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-40322000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66414000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
89601000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14496000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15026000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
174996000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
168961000
CY2023Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0
CY2022Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
8483000
CY2023Q1 us-gaap Inventory Net
InventoryNet
231076000
CY2022Q4 us-gaap Inventory Net
InventoryNet
233854000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31686000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36964000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
504172000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
537863000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
393883000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
392888000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139291000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
148439000
CY2023Q1 us-gaap Goodwill
Goodwill
261143000
CY2022Q4 us-gaap Goodwill
Goodwill
259999000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
644021000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
654965000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39432000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40790000
CY2023Q1 us-gaap Assets
Assets
1588059000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
758604000
CY2022Q4 us-gaap Assets
Assets
1642056000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
52587000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
43998000
CY2023Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
13176000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
17345000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
14356000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126596000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
145779000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
196528000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
217309000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
95768000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
98062000
CY2023Q1 us-gaap Lease Deposit Liability
LeaseDepositLiability
20655000
CY2022Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
22287000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9515000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13561000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
521990000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
532233000
CY2023Q1 us-gaap Liabilities
Liabilities
844456000
CY2022Q4 us-gaap Liabilities
Liabilities
883452000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26381000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26381000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26222000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26222000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
264000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
262000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
901476000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
897028000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77500000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47532000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80637000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91154000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
743603000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
758604000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-29968000
CY2023Q1 zimv Stock Activity Under Stock Plans
StockActivityUnderStockPlans
-391000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4841000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10517000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
743603000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1451377000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-25656000
CY2022Q1 zimv Net Transaction With Zimmer Biomet Holdings Inc
NetTransactionWithZimmerBiometHoldingsInc
-70430000
CY2022Q1 zimv Net Considerations Paid To Zimmer Biomet Holdingsinc
NetConsiderationsPaidToZimmerBiometHoldingsinc
-540567000
CY2022Q1 zimv Reclassification Of Net Parent Company Investment To Additional Paid In Capital
ReclassificationOfNetParentCompanyInvestmentToAdditionalPaidInCapital
0
CY2022Q1 zimv Stock Activity Under Stock Plans
StockActivityUnderStockPlans
-32000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12430000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14666000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
812456000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-29968000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-25656000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32631000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32554000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4841000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13472000
CY2023Q1 zimv Deferred Income Tax Expense Benefit Including Stock Options Exercised
DeferredIncomeTaxExpenseBenefitIncludingStockOptionsExercised
-4208000
CY2022Q1 zimv Deferred Income Tax Expense Benefit Including Stock Options Exercised
DeferredIncomeTaxExpenseBenefitIncludingStockOptionsExercised
-17901000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1556000
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
122000
CY2023Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
7047000
CY2022Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
11258000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4958000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10117000
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-8483000
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
24214000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5431000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8726000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1311000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
15423000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11572000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8639000
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-13176000
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
26368000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4614000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
449000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7196000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9899000
CY2023Q1 zimv Additions To Property Plant And Equipment
AdditionsToPropertyPlantAndEquipment
1951000
CY2022Q1 zimv Additions To Property Plant And Equipment
AdditionsToPropertyPlantAndEquipment
4040000
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1887000
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2047000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1994000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5832000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8087000
CY2023Q1 zimv Payment For Proceeds From Contributions From Parent
PaymentForProceedsFromContributionsFromParent
0
CY2022Q1 zimv Payment For Proceeds From Contributions From Parent
PaymentForProceedsFromContributionsFromParent
6920000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
540567000
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
595000000
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
10519000
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
34000000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5170000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
417000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
157000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10936000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22151000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
777000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-305000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23187000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3860000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89601000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100399000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66414000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104259000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1664000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
494000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8121000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
355000
CY2023Q1 zimv Percentage Of Common Stock Shares Outstanding
PercentageOfCommonStockSharesOutstanding
0.803
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
1500000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1500000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
1491399000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1231400000
CY2022Q4 us-gaap Goodwill
Goodwill
259999000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1144000
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
1492543000
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1231400000
CY2023Q1 us-gaap Goodwill
Goodwill
261143000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1401387000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-746422000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
654965000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1414102000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-770081000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
644021000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
55400000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
72400000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
70600000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
68900000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
63600000
CY2023Q1 zimv Finitelivedintangibleassetsamortizationexpenseafteryearfour
Finitelivedintangibleassetsamortizationexpenseafteryearfour
313100000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
644000000.0
CY2022Q1 zimv Unexercised Stock Option
UnexercisedStockOption
10300000
CY2022Q1 zimv Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Weighted Average Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingWeightedAverageVestingPeriod
P2Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4841000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13472000
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-1209000000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-3148000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3632000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
10324000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5229
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0194
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2403635
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.74
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
63963
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
21.77
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2339672
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.87
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1551483
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.26
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9600000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2022Q1 us-gaap Shares Issued
SharesIssued
26100000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-29968000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-25656000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26263
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26057
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26263
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26057
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3400000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
195733000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
200098000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
23174000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
21199000
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
12169000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12557000
CY2023Q1 us-gaap Inventory Net
InventoryNet
231076000
CY2022Q4 us-gaap Inventory Net
InventoryNet
233854000
CY2023Q1 zimv Expense Benefit Charged To Obsolete Inventories
ExpenseBenefitChargedToObsoleteInventories
-1000000.0
CY2022Q1 zimv Expense Benefit Charged To Obsolete Inventories
ExpenseBenefitChargedToObsoleteInventories
8300000
CY2023Q1 zimv License And Service Agreements
LicenseAndServiceAgreements
23695000
CY2022Q4 zimv License And Service Agreements
LicenseAndServiceAgreements
25337000
CY2023Q1 zimv Salaries Wages And Benefits
SalariesWagesAndBenefits
31479000
CY2022Q4 zimv Salaries Wages And Benefits
SalariesWagesAndBenefits
47812000
CY2023Q1 zimv Lease Liabilities
LeaseLiabilities
9629000
CY2022Q4 zimv Lease Liabilities
LeaseLiabilities
9617000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
61793000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63013000
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
69100000
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
100000
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
600000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126596000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
145779000
CY2023Q1 zimv Term Loan
TermLoan
525938000
CY2022Q4 zimv Term Loan
TermLoan
536456000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3948000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4223000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
521990000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
532233000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
521990000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
532233000
CY2023Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
As of March 31, 2023, our interest rate was the secured overnight financing rate plus the applicable margin of 1.75% for term benchmark borrowings. Commitments under the Revolver are subject to a commitment fee on the unused portion of the Revolver of 25 basis points.
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
55000000.0
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
200000
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
300000
CY2023Q1 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
100000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.153
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 zimv Deferred Tax Liability Increase In Amount Related To Distribution
DeferredTaxLiabilityIncreaseInAmountRelatedToDistribution
3900000
CY2023Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
339000
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
919000
CY2023Q1 zimv Profit Or Loss From Related Party Transactions
ProfitOrLossFromRelatedPartyTransactions
11000
CY2022Q1 zimv Profit Or Loss From Related Party Transactions
ProfitOrLossFromRelatedPartyTransactions
-11897000
CY2022Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
616000
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-20509000
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-20905000
CY2023Q1 zimv Profit Or Loss From Restructuring
ProfitOrLossFromRestructuring
-4975000
CY2022Q1 zimv Profit Or Loss From Restructuring
ProfitOrLossFromRestructuring
-742000
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1683000
CY2022Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-9005000
CY2023Q1 zimv Operating Income Loss Other
OperatingIncomeLossOther
-22238000
CY2022Q1 zimv Operating Income Loss Other
OperatingIncomeLossOther
-20216000
CY2023Q1 us-gaap Revenues
Revenues
225427000
CY2022Q1 us-gaap Revenues
Revenues
235601000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-16126000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-32623000
CY2023Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
7500000
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
9500000
CY2022Q1 zimv Related Party Cash After Distribution
RelatedPartyCashAfterDistribution
100000000.0
CY2023Q1 zimv Restructuring Charges Pre Tax
RestructuringChargesPreTax
3300000
zimv Restructuring Charges Pre Tax
RestructuringChargesPreTax
12300000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
1600000

Files In Submission

Name View Source Status
zimv-20230331_cal.xml Edgar Link unprocessable
0000950170-23-017217-index-headers.html Edgar Link pending
0000950170-23-017217-index.html Edgar Link pending
0000950170-23-017217.txt Edgar Link pending
0000950170-23-017217-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zimv-20230331.htm Edgar Link pending
zimv-20230331.xsd Edgar Link pending
zimv-ex21.htm Edgar Link pending
zimv-ex31_1.htm Edgar Link pending
zimv-ex31_2.htm Edgar Link pending
zimv-ex32_1.htm Edgar Link pending
zimv-ex32_2.htm Edgar Link pending
zimv-20230331_def.xml Edgar Link unprocessable
zimv-20230331_pre.xml Edgar Link unprocessable
zimv-20230331_lab.xml Edgar Link unprocessable
zimv-20230331_htm.xml Edgar Link completed